ADVB Advanced Biomed: Company Book Value

ADVB (Advanced Biomed Inc.) - company brandmark

The Advanced Biomed Inc (ADVB) price chart illustrating trading dynamics shows figures at 0.00. The business relies on external IT providers and laboratories for board production and data storage. The growth strategy is based on integrating systems into oncology center programs, where automated diagnostic modules replace the manual labor of laboratory physicians.

ADVB Advanced Biomed Inc Book Capitalization (03/07/2025 - 10/27/2026)
Mass-produced product of advanbiomed.com

For Advanced Biomed Inc (ADVB), the balance sheet equity serves as an indicator of the real value of assets minus all liabilities. This metric allows investors to filter out market noise by assessing net shareholder equity, which is critical when investing in R&D projects for early cancer diagnosis, where the fundamental value of the business depends directly on the capitalization of intellectual and tangible resources.

Competitors of Advanced Biomed Inc

ONC - Company Book Value|Halozyme Therapeutics (HALO) - Book Capitalization|revmed.com (RVMD) - Company Book Value|Book Capitalization AAPG|Company Net Assets CG Oncology Inc|Book Capitalization URGN|Book Capitalization BCAX (Bicara Corp)|PSNL - Company Book Value|Accounting Capitalization erasca.com ERAS|DCTH: Book Capitalization|YMAB - Company Net Assets|Book Capitalization AURA|CADL (Candel Therapeutics, Inc.) - Total Stockholders' Equity|ARAY - Company Book Value|Accounting Value of Company SELLAS Life Sciences Group Inc. (SLS)|Actuate Therapeutics (ACTU) - Company Net Assets|Accounting Value of Company Citius Oncology Inc. (CTOR)|TuHURA Biosciences - Book Capitalization|TARA - Company Net Assets|Fate Therapeutics, Inc. - Company Net Assets|WHWK: Book Capitalization|Company Book Value tscan.com TCRX|Champions Oncology, Inc. (CSBR) - Accounting Value of Company|Book Capitalization XBIT (XBiotech Inc)|Total Stockholders' Equity CEL-SCI Corp|Book Capitalization OSTX|Book Capitalization Radiopharm Theranostics Ltd (RADX)|ARTV - Book Capitalization|ANL - Accounting Capitalization|VERU - Company Net Assets|TPST - Company Book Value|XLO: Book Capitalization|RENB (Renovaro) - Book Capitalization|Company Book Value Mural Oncology PLC (MURA)|Accounting Capitalization Kairos Pharma Inc|Book Capitalization OKUR (OnKure Therapeutics Inc)|Company Net Assets w2.cytomed.sg (GDTC)|CRIS: Book Capitalization|Total Stockholders' Equity Apollomics Inc. APLM|Tharimmune (THAR) - Book Capitalization|Genprex Inc. (GNPX) - Accounting Capitalization|Company Net Assets calidibio.com CLDI|Sunshine Biopharma Inc. (SBFM) - Accounting Value of Company|Book Capitalization Xenetic Biosciences Inc.|Company Book Value salariuspharma.com|PPBT (Purple Biotech Ltd.) - Book Capitalization|Book Valuation of Business AONC (aoncology.com)|BGNE: Company Book Value|Checkpoint Therapeutics Inc - Total Stockholders' Equity|ELEV: Company Book Value|ICAD - Company Net Assets|Book Capitalization IKNA|Notable Labs Ltd (NTBL) - Total Stockholders' Equity|Book Capitalization Viracta Therapeutics Inc. (VIRX)|Accounting Capitalization MorphoSys Corporation (MOR)|NAYA Biosciences (NAYA) - Company Net Assets|Accounting Value of Company ascentage.com (AAPGV)